Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. / Tobis, Jonathan M.; Elgendy, Akram Y.; Saver, Jeffrey L.; Amin, Zahid; Boudoulas, Konstantinos Dean; Carroll, John D.; Elgendy, Islam Y.; Grunwald, Iris Q.; Gertz, Zachary M.; Hijazi, Ziyad M.; Horlick, Eric M.; Kasner, Scott E.; Kent, David M.; Kumar, Preetham; Kavinsky, Clifford J.; Liebeskind, David S.; Lutsep, Helmi; Mojadidi, Mohammad K.; Messé, Steven R.; Mas, Jean Louis; Mattle, Heinrich P.; Meier, Bernhard; Mahmoud, Ahmad; Mahmoud, Ahmed N.; Nietlispach, Fabian; Patel, Nimesh K.; Rhodes, John F.; Reisman, Mark; Sommer, Robert J.; Sievert, Horst; Søndergaard, Lars; Zaman, Muhammad O.; Thaler, David.

I: JAMA Neurology, Bind 77, Nr. 7, 2020, s. 878-886.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Tobis, JM, Elgendy, AY, Saver, JL, Amin, Z, Boudoulas, KD, Carroll, JD, Elgendy, IY, Grunwald, IQ, Gertz, ZM, Hijazi, ZM, Horlick, EM, Kasner, SE, Kent, DM, Kumar, P, Kavinsky, CJ, Liebeskind, DS, Lutsep, H, Mojadidi, MK, Messé, SR, Mas, JL, Mattle, HP, Meier, B, Mahmoud, A, Mahmoud, AN, Nietlispach, F, Patel, NK, Rhodes, JF, Reisman, M, Sommer, RJ, Sievert, H, Søndergaard, L, Zaman, MO & Thaler, D 2020, 'Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke', JAMA Neurology, bind 77, nr. 7, s. 878-886. https://doi.org/10.1001/jamaneurol.2020.0458

APA

Tobis, J. M., Elgendy, A. Y., Saver, J. L., Amin, Z., Boudoulas, K. D., Carroll, J. D., Elgendy, I. Y., Grunwald, I. Q., Gertz, Z. M., Hijazi, Z. M., Horlick, E. M., Kasner, S. E., Kent, D. M., Kumar, P., Kavinsky, C. J., Liebeskind, D. S., Lutsep, H., Mojadidi, M. K., Messé, S. R., ... Thaler, D. (2020). Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. JAMA Neurology, 77(7), 878-886. https://doi.org/10.1001/jamaneurol.2020.0458

Vancouver

Tobis JM, Elgendy AY, Saver JL, Amin Z, Boudoulas KD, Carroll JD o.a. Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. JAMA Neurology. 2020;77(7):878-886. https://doi.org/10.1001/jamaneurol.2020.0458

Author

Tobis, Jonathan M. ; Elgendy, Akram Y. ; Saver, Jeffrey L. ; Amin, Zahid ; Boudoulas, Konstantinos Dean ; Carroll, John D. ; Elgendy, Islam Y. ; Grunwald, Iris Q. ; Gertz, Zachary M. ; Hijazi, Ziyad M. ; Horlick, Eric M. ; Kasner, Scott E. ; Kent, David M. ; Kumar, Preetham ; Kavinsky, Clifford J. ; Liebeskind, David S. ; Lutsep, Helmi ; Mojadidi, Mohammad K. ; Messé, Steven R. ; Mas, Jean Louis ; Mattle, Heinrich P. ; Meier, Bernhard ; Mahmoud, Ahmad ; Mahmoud, Ahmed N. ; Nietlispach, Fabian ; Patel, Nimesh K. ; Rhodes, John F. ; Reisman, Mark ; Sommer, Robert J. ; Sievert, Horst ; Søndergaard, Lars ; Zaman, Muhammad O. ; Thaler, David. / Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. I: JAMA Neurology. 2020 ; Bind 77, Nr. 7. s. 878-886.

Bibtex

@article{196a7e31b8b64c06b84f8f5d0b92bdc7,
title = "Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke",
abstract = "Importance: Recent epidemiologic and therapeutic advances have transformed understanding of the role of and therapeutic approach to patent foramen ovale (PFO) in ischemic stroke. Patent foramen ovale is likely responsible for approximately 5% of all ischemic strokes and 10% of those occurring in young and middle-aged adults. Observations: Randomized clinical trials have demonstrated that, to prevent recurrent ischemic stroke in patients with PFO and an otherwise-cryptogenic index ischemic stroke, PFO closure is superior to antiplatelet medical therapy alone; these trials have provided some evidence that, among medical therapy options, anticoagulants may be more effective than antiplatelet agents. Conclusions and Relevance: These new data indicate a need to update classification schemes of causative mechanisms in stroke, developed in an era in which an association between PFO and stroke was viewed as uncertain. We propose a revised general nomenclature and classification framework for PFO-associated stroke and detailed revisions for the 3 major stroke subtyping algorithms in wide use. ",
author = "Tobis, {Jonathan M.} and Elgendy, {Akram Y.} and Saver, {Jeffrey L.} and Zahid Amin and Boudoulas, {Konstantinos Dean} and Carroll, {John D.} and Elgendy, {Islam Y.} and Grunwald, {Iris Q.} and Gertz, {Zachary M.} and Hijazi, {Ziyad M.} and Horlick, {Eric M.} and Kasner, {Scott E.} and Kent, {David M.} and Preetham Kumar and Kavinsky, {Clifford J.} and Liebeskind, {David S.} and Helmi Lutsep and Mojadidi, {Mohammad K.} and Mess{\'e}, {Steven R.} and Mas, {Jean Louis} and Mattle, {Heinrich P.} and Bernhard Meier and Ahmad Mahmoud and Mahmoud, {Ahmed N.} and Fabian Nietlispach and Patel, {Nimesh K.} and Rhodes, {John F.} and Mark Reisman and Sommer, {Robert J.} and Horst Sievert and Lars S{\o}ndergaard and Zaman, {Muhammad O.} and David Thaler",
year = "2020",
doi = "10.1001/jamaneurol.2020.0458",
language = "English",
volume = "77",
pages = "878--886",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "The JAMA Network",
number = "7",

}

RIS

TY - JOUR

T1 - Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke

AU - Tobis, Jonathan M.

AU - Elgendy, Akram Y.

AU - Saver, Jeffrey L.

AU - Amin, Zahid

AU - Boudoulas, Konstantinos Dean

AU - Carroll, John D.

AU - Elgendy, Islam Y.

AU - Grunwald, Iris Q.

AU - Gertz, Zachary M.

AU - Hijazi, Ziyad M.

AU - Horlick, Eric M.

AU - Kasner, Scott E.

AU - Kent, David M.

AU - Kumar, Preetham

AU - Kavinsky, Clifford J.

AU - Liebeskind, David S.

AU - Lutsep, Helmi

AU - Mojadidi, Mohammad K.

AU - Messé, Steven R.

AU - Mas, Jean Louis

AU - Mattle, Heinrich P.

AU - Meier, Bernhard

AU - Mahmoud, Ahmad

AU - Mahmoud, Ahmed N.

AU - Nietlispach, Fabian

AU - Patel, Nimesh K.

AU - Rhodes, John F.

AU - Reisman, Mark

AU - Sommer, Robert J.

AU - Sievert, Horst

AU - Søndergaard, Lars

AU - Zaman, Muhammad O.

AU - Thaler, David

PY - 2020

Y1 - 2020

N2 - Importance: Recent epidemiologic and therapeutic advances have transformed understanding of the role of and therapeutic approach to patent foramen ovale (PFO) in ischemic stroke. Patent foramen ovale is likely responsible for approximately 5% of all ischemic strokes and 10% of those occurring in young and middle-aged adults. Observations: Randomized clinical trials have demonstrated that, to prevent recurrent ischemic stroke in patients with PFO and an otherwise-cryptogenic index ischemic stroke, PFO closure is superior to antiplatelet medical therapy alone; these trials have provided some evidence that, among medical therapy options, anticoagulants may be more effective than antiplatelet agents. Conclusions and Relevance: These new data indicate a need to update classification schemes of causative mechanisms in stroke, developed in an era in which an association between PFO and stroke was viewed as uncertain. We propose a revised general nomenclature and classification framework for PFO-associated stroke and detailed revisions for the 3 major stroke subtyping algorithms in wide use.

AB - Importance: Recent epidemiologic and therapeutic advances have transformed understanding of the role of and therapeutic approach to patent foramen ovale (PFO) in ischemic stroke. Patent foramen ovale is likely responsible for approximately 5% of all ischemic strokes and 10% of those occurring in young and middle-aged adults. Observations: Randomized clinical trials have demonstrated that, to prevent recurrent ischemic stroke in patients with PFO and an otherwise-cryptogenic index ischemic stroke, PFO closure is superior to antiplatelet medical therapy alone; these trials have provided some evidence that, among medical therapy options, anticoagulants may be more effective than antiplatelet agents. Conclusions and Relevance: These new data indicate a need to update classification schemes of causative mechanisms in stroke, developed in an era in which an association between PFO and stroke was viewed as uncertain. We propose a revised general nomenclature and classification framework for PFO-associated stroke and detailed revisions for the 3 major stroke subtyping algorithms in wide use.

UR - http://www.scopus.com/inward/record.url?scp=85083188518&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2020.0458

DO - 10.1001/jamaneurol.2020.0458

M3 - Journal article

C2 - 32282016

AN - SCOPUS:85083188518

VL - 77

SP - 878

EP - 886

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 7

ER -

ID: 259987870